PharmaShots Weekly Snapshot (February 25 – March 01,2019)

1.Novavax Reports Results of ResVax in P-III PREPARE Trial for Prevention of RSV Disease in Infants via Maternal Immunization

Published: 01 Mar,2019 |Tags: Novavax; Reports; Results; ResVax; P-III; PREPARE study; RSV Disease; Infants

2. Johnson & Johnson (J&J) Collaborates with AdoRx Therapeutics to Develop Therapies for Lung Cancer

Published: 01 Mar,2019 |Tags: Johnson & Johnson; Collaborates; AdoRx Therapeutics; Develop; Novel; Therapies; Lung Cancer

3. Alvogen Expands Development and Commercialization Collaboration with Pfenex for PF708 in EU, MENA and ROW

Published: 01 Mar,2019 |Tags: Pfenex; Expands; Development; Commercialization; Collaboration; Alvogen; PF708; EU; MENA; ROW

4. Biogen’s Spinraza (nusinersen) Receives NMPA (CFDA) Approval for Spinal Muscular Atrophy (SMA) Aged 6wks.

Published: 01 Mar,2019 |Tags: Biogen; Spinraza; nusinersen; Receives; NMPA; CFDA; Approval; Spinal Muscular Atrophy; SMA; Aged; 6wks

5. Roche’s Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) Receives FDA’s Approval for Patients with HER2-Positive Breast Cancers

Published: 01 Mar,2019 |Tags: Roche; Herceptin Hylecta; trastuzumab and hyaluronidase-oysk; Receives; FDA Approval; Patients; HER2-positive; Breast Cancers

6. AbCellera and Denali Therapeutics Expand Collaboration to Develop Abs for Neurological Disorders

Published: 28 Feb,2019 |Tags: AbCellera; Expand; Collaboration; Denali Therapeutics; Develop; Abs; Neurological Disorders

7. Novartis and Blackstone Life Sciences Collaborate to Launch Anthos Therapeutics for Cardiovascular Disorders

Published: 28 Feb,2019 |Tags: Novartis; Blackstone Life Sciences; Collaborates; Launch; Anthos Therapeutics; Cardiovascular Disorders

8. Novartis Signs a Research Agreement with Target PharmaSolutions for Conducting TARGET-DERM Study

Published: 28 Feb,2019 |Tags: Novartis; Signs; Research; Agreement; Target PharmaSolutions; Conducting; TARGET-DERM; Study

9. Janssen’s Tremfya (guselkumab) Receives FDA’s Approval for Moderate-to-Severe Plaque Psoriasis in Adults

Published: 28 Feb,2019 |Tags: Janssen; Tremfya; guselkumab; Receives; FDA; Approval; Moderate-to-Severe; Plaque; Psoriasis; Adults

10. AstraZeneca’s Farxiga and Xigduo XR Receives FDA’s Expanded Label Approval for Type 2 Diabetes (T2D) and Moderate Renal Impairment

Published: 28 Feb,2019 |Tags: AstraZeneca; Farxiga; Xigduo XR; Receives; FDA; Expanded Label Approval; Type 2 Diabetes; T2D; Moderate Renal Impairment

11. Sarepta Exercises its Exclusive Option to Acquire Myngonexus Therapeutics for $165M

Published: 27 Feb,2019 |Tags: Sarepta; Exercises; Exclusive; Option to Acquire; Myngonexus Therapeutics; $165M

12. Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA’s Approval for Expanded Indication for Chronic Total Occlusion (CTO)

Published: 27 Feb,2019 |Tags: Medtronic; Resolute; Drug-Eluting Stent (DES) Platforml; Receives; FDA; Approval; Expanded; Indication; Chronic Total Occlusion; CTO

13. Imbrium Signs a License Agreement with TetraGenetics for its TetraExpress Technology

Published: 27 Feb,2019 |Tags: Imbrium; Signs; License; Agreement; TetraGenetics; TetraExpress Technology; Ab-based; Autoimmune disorders; Pain

14. Roche and Immatics Collaborate to Evaluate IMA101 + Tecentriq (atezolizumab) for Solid Cancers

Published: 27 Feb,2019 |Tags: Roche; Immatics; Collaborates; Evaluate; IMA101; Tecentriq; atezolizumab; Solid Cancers

15. AstraZeneca & Merck Report Result of Lynparza (olaparib) in P-III POLO Trial for BRCA-Mutated Metastatic Pancreatic Cancer

Published: 27 Feb,2019 |Tags: AstraZeneca; Reports; Results; Lynparza; olaparib; P-III; POLO Trial; BRCA-Mutated Metastatic Pancreatic; Cancer

16. Genmab Reports Results of Darzalex (daratumumab) in P-III COLUMBA Study for Patients with R/R Multiple Myeloma

Published: 26 Feb,2019 | Tags: Genmab; Reports; Results; Darzalex; daratumumab; SC; P-III; COLUMBA; Study; Patients; R/R; Multiple Myeloma

17. Amgen Reports In-Favor Uphold of its Two Patents for Repatha from Delaware Jury

Published: 26 Feb,2019 |Tags: Amgen; Reports; In-Favor Uphold; Patents; Repatha; Delaware Jury

18. Ipsen to Acquire Clementia Pharmaceuticals for $1.31B to Expand its Rare Disease Portfolio

Published: 26 Feb,2019 |Tags: Ipsen; Acquire; Clementia Pharmaceuticals; $1.31B; Expand; Rare Disease; Portfolio

19. Novartis Exercises its Option to License AKCEA-APO(a)-LRx from Akcea

Published: 26 Feb,2019 |Tags: Novartis; Exercises; Option to License; AKCEA-APO(a)-LRx; Akcea

20. Danaher to Acquire Biopharma Unit of GE LifeScience for $21.4B

Published: 26 Feb,2019 | Tags: Danaher; Acquire; GE Biopharma; $21.4B

21. Santhera Reports Results of Raxone (Idebenone) in P-III DELOS trial for Patients with Duchenne Muscular Dystrophy (DMD)

Published: 25 Feb,2019 | Tags: Santhera; Reports; Results; Raxone; Idebenone; P-III; DELOS trial; Patients; Duchenne Muscular Dystrophy; DMD

22. AbbVie Signs an Exclusive Worldwide Research Collaboration with Voyager Therapeutics for Vectorized Abs

Published: 25 Feb,2019 |Tags: AbbVie; Signs; Research; Exclusive; WW; Collaboration; Agreement; Voyager Therapeutics; Vectorized Antibodies

23. Roche to Acquire Spark Therapeutics for $4.3B

Published: 25 Feb,2019 |Tags: Roche; Acquire; Spark Therapeutics; $4.3B; Genetic diseases

24. AstraZeneca Reports Results of Brilinta (ticagrelor) in P-III THEMIS Trial for Patients with Coronary Artery Disease (CAD) and Type-2 Diabetes (T2D)

Published: 25 Feb,2019 | Tags: AstraZeneca; Reports; Results; Brilinta; ticagrelor; P-III; THEMIS Trial; Patients; No; Prior; Heart Attack; Stroke

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post